Literature Reviews

The article by Paul McCarthy in the May 30, 1994, issue of The Scientist [page 1] on peer review struck a responsive note. I, too, have come to distrust journal reviewers and National Institutes of Health pink sheets despite good fortune with publications and grants over many years. Responsibility and devotion are far less than they were one and two generations ago, perhaps a mirror of our end-of- century society. But I have a solu

Written byThomas Maren
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article by Paul McCarthy in the May 30, 1994, issue of The Scientist [page 1] on peer review struck a responsive note. I, too, have come to distrust journal reviewers and National Institutes of Health pink sheets despite good fortune with publications and grants over many years. Responsibility and devotion are far less than they were one and two generations ago, perhaps a mirror of our end-of- century society.

But I have a solution, at least for journal reviews. I do favor signed reviews, but this will probably never fly. But why shouldn't reviewers be required to document their comments, citing appropriate literature? Can't these godlike, nameless shadows be brought into scientific focus?

THOMAS H. MAREN
University of Florida
College of Medicine
P.O. Box 100267
Gainesville, Fla. 32620-0267

(The Scientist, Vol:8, #16, pg.13, August 22, 1994) (Copyright, The Scientist, Inc.)

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies